When.com Web Search

  1. Ads

    related to: contrave vs qsymia xenical 5 tab er

Search results

  1. Results From The WOW.Com Content Network
  2. Naltrexone/bupropion - Wikipedia

    en.wikipedia.org/wiki/Naltrexone/bupropion

    Naltrexone/bupropion, sold under the brand name Contrave among others, is a fixed-dose combination medication for the management of chronic obesity in adults in combination with a reduced-calorie diet and increased physical activity.

  3. 15 Alternatives to Ozempic for Weight Loss - AOL

    www.aol.com/15-alternatives-ozempic-weight-loss...

    Like many Ozempic alternatives, Qsymia is FDA-approved for weight management in people with a BMI of 30 or more, or 27 or more with a weight-related condition. Research shows that treatment with ...

  4. Adherence to weight-loss drugs is far higher with ... - AOL

    www.aol.com/news/adherence-weight-loss-drugs-far...

    Only 13% of patients who started taking Contrave from Orexigen Therapeutics and 10% of those who started on Qsymia from Vivus between 2015 and 2022 were still filling their prescriptions a year ...

  5. Anti-obesity medication - Wikipedia

    en.wikipedia.org/wiki/Anti-obesity_medication

    Qsymia Phentermine is a substituted amphetamine and topiramate has an unknown mechanism of action Approved for weight management (short-term) by the FDA but not the European Medicines Agency [54] 10% [55] or 8.25 kilograms (18.2 lb) [56] Naltrexone/bupropion: Contrave Approved for weight management (chronic) in the US and EU [57] 5 percent [17 ...

  6. What's the difference between Ozempic and Zepbound? Our ... - AOL

    www.aol.com/lifestyle/whats-difference-between...

    It's sold under the names Xenical and Alli. Phentermine-topiramate. Sold under the brand name Qsymia, it is a combination of the drugs phentermine and topiramate, which are taken orally. The ...

  7. Orexigen Therapeutics - Wikipedia

    en.wikipedia.org/wiki/Orexigen_Therapeutics

    The company has a single product, Contrave, approved for use in the United States in 2014. [ 2 ] [ 3 ] Contrave was designed not only to curb hunger but also reduce cravings. [ 3 ] Observation of the market performance of Qsymia and Belviq suggest overall low demand for pharmaceutical obesity therapies, calling into question earnings potential ...